| Literature DB >> 31267348 |
Marta Balzarini1, Valentina Rovelli2, Sabrina Paci2, Miriam Rigoldi3, Giuseppina Sanna4, Sara Pillai4, Marilisa Asunis5, Rossella Parini3,6, Bianca Maria Ciminelli7, Patrizia Malaspina8.
Abstract
Succinic semialdehyde dehydrogenase deficiency (SSADHD) is a rare autosomal recessive disorder of γ-aminobutyric acid (GABA) catabolism caused by mutations in the gene coding for succinic semialdehyde dehydrogenase (ALDH5A1). The abnormal levels of GHB detected in the brain and in all physiological fluids of SSADHD patients represent a diagnostic biochemical hallmark of the disease. Here we report on the clinical and molecular characterization of two unrelated Italian patients and the identification of two novel mutations: a 22 bp DNA duplication in exon 1, c.114_135dup, p.(C46AfsX97), and a non-sense mutation in exon 10, c.1429C > T, p.(Q477X). The two patients showed very different clinical phenotypes, coherent with their age. These findings enrich the characterization of SSADHD families and contribute to the knowledge on the progression of the disease.Entities:
Keywords: 4-HBA (4-hydroxybutiric aciduria); ALDH5A1 gene; GABA (γ-aminobutyric acid); GHB (γ-hydroxybutyric acid); SSADHD (succinic semialdehyde dehydrogenase deficiency)
Mesh:
Substances:
Year: 2019 PMID: 31267348 DOI: 10.1007/s11011-019-00453-w
Source DB: PubMed Journal: Metab Brain Dis ISSN: 0885-7490 Impact factor: 3.584